Kala Visvanathan, MD, MBBS, MHS, discusses the rationale for evaluating lipophilic statins in epithelial ovarian cancer.
Kala Visvanathan, MD, MBBS, MHS
Advertisement
Articles by Kala Visvanathan, MD, MBBS, MHS
Advertisement
Latest Updated Articles
Dr. Visvanathan on the Rationale for Evaluating Lipophilic Statins in Epithelial Ovarian CancerPublished: September 9th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5